結構性心臟疾病封堵器的開發平台 - 開發階段，市場區隔，地區，法規途徑，主要企業

本報告提供結構性心臟疾病封堵器的開發中產品調查分析，包含各種正在開發階段的產品的比較分析，及進行中的臨床試驗資料等全面性資訊。

目錄

第1章 目錄

第2章 簡介

第3章 開發中的產品

• 結構性心臟疾病封堵器 - 開發中產品:各開發階段
• 結構性心臟疾病封堵器 - 開發中產品:各市場區隔
• 結構性心臟疾病封堵器 - 開發中產品:各地區
• 結構性心臟疾病封堵器 - 開發中產品:各法規途徑
• 結構用心臟封堵器 - 開發中產品:各估計核准日
• 結構性心臟疾病封堵器 - 進行中的臨床試驗

第4章 結構型心臟封堵器 - 正在開發的開發中產品:各企業

• 結構性心臟疾病封堵器企業 - 開發中產品:各開發階段
• 結構性心臟疾病封堵器 - 開發中產品:各開發階段

第5章 結構性心臟疾病封堵器的企業和產品概要

• Abbott Japan Co Ltd:企業概要
  • Abbott Japan Co Ltd:開發中產品和進行中的臨床試驗概要
• Aegis Medical Innovations Inc.:企業概要
  • Aegis Medical Innovations Inc.:開發中產品和進行中的臨床試驗概要
• Aporo Biomedical, Inc.(暫停中):企業概要
  • Aporo Biomedical, Inc.(暫停中):開發中產品和進行中的臨床試驗概要
• Append Medical:企業概要
  • Append Medical:開發中產品和進行中的臨床試驗概要
• atHeart Medical:企業概要
  • atHeart Medical:開發中產品和進行中的臨床試驗概要
• AuriGen Medical Ltd:企業概要
  • AuriGen Medical Ltd:開發中產品和進行中的臨床試驗概要
• Boston Scientific Corp:企業概要
  • Boston Scientific Corp:開發中產品和進行中的臨床試驗概要
• CARAG AG:企業概要
  • CARAG AG:開發中產品和進行中的臨床試驗概要
• Cierra, Inc.(暫停中):企業概要
  • Cierra, Inc.(暫停中):開發中產品和進行中的臨床試驗概要
• Conformal Medical Inc:企業概要
  • Conformal Medical Inc:開發中產品和進行中的臨床試驗概要
• Cor Habere Corp:企業概要
  • Cor Habere Corp:開發中產品和進行中的臨床試驗概要
• Dextera Surgical Inc:企業概要
  • Dextera Surgical Inc:開發中產品和進行中的臨床試驗概要
• Endomimetics LLC:企業概要
  • Endomimetics LLC:開發中產品和進行中的臨床試驗概要
• Ension, Inc.:企業概要
  • Ension, Inc.:開發中產品和進行中的臨床試驗概要
• Guangdong Pulse Medical Technology Co Ltd:企業概要
  • Guangdong Pulse Medical Technology Co Ltd:開發中產品和進行中的臨床試驗概要
• Hangzhou Dinova EP Technology Co Ltd:企業概要
  • Hangzhou Dinova EP Technology Co Ltd:開發中產品和進行中的臨床試驗概要
• Hansen Medical Inc(暫停中):企業概要
  • Hansen Medical Inc(暫停中):開發中產品和進行中的臨床試驗概要
• Jenscare Scientific Co Ltd:企業概要
  • Jenscare Scientific Co Ltd:開發中產品和進行中的臨床試驗概要
• Laminar Inc:企業概要
  • Laminar Inc:開發中產品和進行中的臨床試驗概要
• Lepu Scientech Medical Technology (Shanghai) Co Ltd:企業概要
  • Lepu Scientech Medical Technology (Shanghai) Co Ltd:開發中產品和進行中的臨床試驗概要
• Lifetech Scientific (深圳) Co Ltd:企業概要
  • Lifetech Scientific (深圳) Co Ltd:開發中產品和進行中的臨床試驗概要
• LuSeed Vascular:企業概要
  • LuSeed Vascular:開發中產品和進行中的臨床試驗概要
• Mayo Clinic:企業概要
  • Mayo Clinic:開發中產品和進行中的臨床試驗概要
• Medtronic Plc:企業概要
  • Medtronic Plc:開發中產品和進行中的臨床試驗概要
• Micro Interventional Devices, Inc.:企業概要
  • Micro Interventional Devices, Inc.:開發中產品和進行中的臨床試驗概要
• Northwestern University:企業概要
  • Northwestern University:開發中產品和進行中的臨床試驗概要
• Occlutech International AB:企業概要
  • Occlutech International AB:開發中產品和進行中的臨床試驗概要
• SentreHEART Inc:企業概要
  • SentreHEART Inc:開發中產品和進行中的臨床試驗概要
• SeptRx, Inc.(暫停中):企業概要
  • SeptRx, Inc.(暫停中):開發中產品和進行中的臨床試驗概要
• Shanghai Shenqi Medical Technology Co Ltd:企業概要
  • Shanghai Shenqi Medical Technology Co Ltd:開發中產品和進行中的臨床試驗概要
• Swissimplant AG:企業概要
  • Swissimplant AG:開發中產品和進行中的臨床試驗概要
• The Chaim Sheba Medical Center:企業概要
  • The Chaim Sheba Medical Center:開發中產品和進行中的臨床試驗概要
• University of Minnesota:企業概要
  • University of Minnesota:開發中產品和進行中的臨床試驗概要
• Vascular Closure Systems Inc:企業概要
  • Vascular Closure Systems Inc:開發中產品和進行中的臨床試驗概要
• Vascular Concepts Ltd:企業概要
  • Vascular Concepts Ltd:開發中產品和進行中的臨床試驗概要
• W. L. Gore & Associates Inc:企業概要
  • W. L. Gore & Associates Inc:開發中產品和進行中的臨床試驗概要
• Worry Free Beating:企業概要
  • Worry Free Beating:開發中產品和進行中的臨床試驗概要

第6章 結構性心臟疾病封堵器 - 近幾年的發展

第7章 附錄

Abstract

GlobalData's Medical Devices sector report, "Structural Heart Occluders Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" provides comprehensive information about the Structural Heart Occluders pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Structural heart occluders are used for treatment congenital heart defects by closing openings in the heart. Structural heart occluders covers left atrial appendage closure devices, atrial septal defect occluders, ventricular septal defect occluders, patent foramen ovale closure devices, patent ductus arteriosus closure devices.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

• Extensive coverage of the Structural Heart Occluders under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Structural Heart Occluders and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Structural Heart Occluders under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Structural Heart Occluders Overview

3 Products under Development

• 3.1 Structural Heart Occluders - Pipeline Products by Stage of Development
• 3.2 Structural Heart Occluders - Pipeline Products by Segment
• 3.3 Structural Heart Occluders - Pipeline Products by Territory
• 3.4 Structural Heart Occluders - Pipeline Products by Regulatory Path
• 3.5 Structural Heart Occluders - Pipeline Products by Estimated Approval Date
• 3.6 Structural Heart Occluders - Ongoing Clinical Trials

4 Structural Heart Occluders - Pipeline Products under Development by Companies

• 4.1 Structural Heart Occluders Companies - Pipeline Products by Stage of Development
• 4.2 Structural Heart Occluders - Pipeline Products by Stage of Development

5 Structural Heart Occluders Companies and Product Overview

• 5.1 Abbott Japan Co Ltd Company Overview
  • 5.1.1 Abbott Japan Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.2 Aegis Medical Innovations Inc. Company Overview
  • 5.2.1 Aegis Medical Innovations Inc. Pipeline Products & Ongoing Clinical Trials Overview
• 5.3 Aporo Biomedical, Inc. (Inactive) Company Overview
  • 5.3.1 Aporo Biomedical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
• 5.4 Append Medical Company Overview
  • 5.4.1 Append Medical Pipeline Products & Ongoing Clinical Trials Overview
• 5.5 atHeart Medical Company Overview
  • 5.5.1 atHeart Medical Pipeline Products & Ongoing Clinical Trials Overview
• 5.6 AuriGen Medical Ltd Company Overview
  • 5.6.1 AuriGen Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.7 Boston Scientific Corp Company Overview
  • 5.7.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.8 CARAG AG Company Overview
  • 5.8.1 CARAG AG Pipeline Products & Ongoing Clinical Trials Overview
• 5.9 Cierra, Inc. (Inactive) Company Overview
  • 5.9.1 Cierra, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
• 5.10 Conformal Medical Inc Company Overview
  • 5.10.1 Conformal Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.11 Cor Habere Corp Company Overview
  • 5.11.1 Cor Habere Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.12 Dextera Surgical Inc Company Overview
  • 5.12.1 Dextera Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.13 Endomimetics LLC Company Overview
  • 5.13.1 Endomimetics LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.14 Ension, Inc. Company Overview
  • 5.14.1 Ension, Inc. Pipeline Products & Ongoing Clinical Trials Overview
• 5.15 Guangdong Pulse Medical Technology Co Ltd Company Overview
  • 5.15.1 Guangdong Pulse Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.16 Hangzhou Dinova EP Technology Co Ltd Company Overview
  • 5.16.1 Hangzhou Dinova EP Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.17 Hansen Medical Inc (Inactive) Company Overview
  • 5.17.1 Hansen Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
• 5.18 Jenscare Scientific Co Ltd Company Overview
  • 5.18.1 Jenscare Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.19 Laminar Inc Company Overview
  • 5.19.1 Laminar Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.20 Lepu Scientech Medical Technology (Shanghai) Co Ltd Company Overview
  • 5.20.1 Lepu Scientech Medical Technology (Shanghai) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.21 Lifetech Scientific (Shenzhen) Co Ltd Company Overview
  • 5.21.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.22 LuSeed Vascular Company Overview
  • 5.22.1 LuSeed Vascular Pipeline Products & Ongoing Clinical Trials Overview
• 5.23 Mayo Clinic Company Overview
  • 5.23.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
• 5.24 Medtronic Plc Company Overview
  • 5.24.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
• 5.25 Micro Interventional Devices, Inc. Company Overview
  • 5.25.1 Micro Interventional Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview
• 5.26 Northwestern University Company Overview
  • 5.26.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
• 5.27 Occlutech International AB Company Overview
  • 5.27.1 Occlutech International AB Pipeline Products & Ongoing Clinical Trials Overview
• 5.28 SentreHEART Inc Company Overview
  • 5.28.1 SentreHEART Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.29 SeptRx, Inc. (Inactive) Company Overview
  • 5.29.1 SeptRx, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
• 5.30 Shanghai Shenqi Medical Technology Co Ltd Company Overview
  • 5.30.1 Shanghai Shenqi Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.31 Swissimplant AG Company Overview
  • 5.31.1 Swissimplant AG Pipeline Products & Ongoing Clinical Trials Overview
• 5.32 The Chaim Sheba Medical Center Company Overview
  • 5.32.1 The Chaim Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview
• 5.33 University of Minnesota Company Overview
  • 5.33.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
• 5.34 Vascular Closure Systems Inc Company Overview
  • 5.34.1 Vascular Closure Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.35 Vascular Concepts Ltd Company Overview
  • 5.35.1 Vascular Concepts Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.36 W. L. Gore & Associates Inc Company Overview
  • 5.36.1 W. L. Gore & Associates Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.37 Worry Free Beating Company Overview
  • 5.37.1 Worry Free Beating Pipeline Products & Ongoing Clinical Trials Overview

6 Structural Heart Occluders- Recent Developments

• 6.1 Nov 13, 2023: Jenscare : Simulock Successfully Completes Implantation Surgery for the First Confirmatory Clinical Trial
• 6.2 Oct 24, 2023: Conformal Medical Announces Compelling One-Year Data from its Left Atrial Appendage Occlusion (LAAO) Early Feasibility Study
• 6.3 Oct 17, 2023: The Gore Relief Clinical Study Begins Randomizing Patients to Evaluate PFO Closure for Migraine Headache Relief
• 6.4 Sep 07, 2023: Boston Scientific's LAAC device gets FDA approval
• 6.5 Sep 06, 2023: Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX Pro Left Atrial Appendage Closure Device
• 6.6 May 17, 2023: MicroPort's LAA closure AnchorMan device achieves primary endpoint from SAFE PROTECT clinical trial, showing very promising results
• 6.7 Feb 27, 2023: Study demonstrates successful device size selection when assessing left atrial appendage by angiography compared to TEE
• 6.8 Jan 31, 2023: Conformal Medical announces positive one-year data from its left atrial appendage closure performed under conscious sedation study
• 6.9 Jan 05, 2023: JSCAI publishes peer-reviewed article highlighting effective performance of conformal medical's Left Atrial Appendage (CLAAS) Device
• 6.10 Dec 06, 2022: Henry Ford Health to lead first-of-its-kind national trial for innovative heart device

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us
• 7.4 Disclaimer

List of Tables

List of Tables

• Structural Heart Occluders - Pipeline Products by Stage of Development
• Structural Heart Occluders - Pipeline Products by Segment
• Structural Heart Occluders - Pipeline Products by Territory
• Structural Heart Occluders - Pipeline Products by Regulatory Path
• Structural Heart Occluders - Pipeline Products by Estimated Approval Date
• Structural Heart Occluders - Ongoing Clinical Trials
• Structural Heart Occluders Companies - Pipeline Products by Stage of Development
• Structural Heart Occluders - Pipeline Products by Stage of Development
• Glossary

List of Figures

List of Figures

• Structural Heart Occluders - Pipeline Products by Stage of Development
• Structural Heart Occluders - Pipeline Products by Segment
• Structural Heart Occluders - Pipeline Products by Territory
• Structural Heart Occluders - Pipeline Products by Regulatory Path
• Structural Heart Occluders - Pipeline Products by Estimated Approval Date
• Structural Heart Occluders - Ongoing Clinical Trials